CJC-1295 without DAC 10mg + IPA 10mg
CJC-1295 without DAC 10mg + IPA 10mg from the Nexus Growth Hormone Secretagogues catalog, supplied for controlled in-vitro research workflows.
Ships from the US with tracking.
Catalog active: Catalog pricing is active. Live warehouse counts are not published.
Certificate pending — assay values withheld
Final assay values publish here once independent documentation is available. See the verification process.
For in-vitro research use only. Not for human consumption.
This blend combines two complementary GH-axis peptides. CJC-1295 No DAC stimulates the GHRH receptor on pituitary somatotrophs, while Ipamorelin activates the ghrelin receptor (GHSR-1a). This dual-receptor approach targets two independent pituitary signaling pathways, which research suggests may produce synergistic GH release.
No sequence is listed in the current catalog record for this product.
- CAS
- N/A
- MW
- CJC-1295: 3367.97 g/mol + Ipamorelin: 711.85 g/mol
- Sequence
- Not listed
- Half-life
- Not listed
- Formula
- Not listed
- Purity
- Certificate pending
- Form
- Lyophilized powder
- Class
- Dual-Pathway GH Research Blend
The dossier.
Compound Overview
This research blend pairs two complementary GH-axis peptides in one lyophilized format. CJC-1295 No DAC acts at the GHRH receptor on pituitary somatotrophs, while Ipamorelin acts through the ghrelin receptor (GHSR-1a). By engaging two separate pituitary signaling routes, the combination is used in controlled research models examining whether dual-receptor stimulation may produce synergistic GH release.
Research Background & Published Literature
The CJC-1295/Ipamorelin pairing is widely evaluated in preclinical GH-axis research because it combines GHRH receptor activity with ghrelin receptor stimulation. Published work reviews how concurrent activation of these pathways may amplify GH output compared with either peptide studied alone.
Researchers reviewing the literature around this compound can use the peer-reviewed resources below for additional context on mechanism of action, signaling pathways, and controlled laboratory research applications:
Storage, Handling & Stability Guidelines
Use the applicable lot/source record for storage of unopened material. Any diluent selection, preparation, temperature, aliquoting, or post-reconstitution hold conditions must be established by a qualified laboratory under a validated SOP; this page does not establish a stability window.
- Keep ambient-temperature exposure brief during handling to help preserve compound integrity.
- Reseal vials promptly after each withdrawal to reduce moisture exposure.
- Use appropriate personal protective equipment and follow institutional chemical safety protocols at all times.
- For traceability, label all aliquots with compound name, concentration, reconstitution date, and operator initials.
Quality Assurance & Lab Verification
The Certificate of Analysis for this catalog item is pending. No provisional batch, assay, method, analyst, or release data is published in this product dossier. Check the Lab Verified archive for documentation status.
Shipping
Orders ship within the United States via USPS; international orders are not accepted. Laboratories should follow their validated SOP together with any handling fields published for the represented product or lot; no universal prepared-solution condition is inferred here.
Compound details.
- Molecular Weight
- CJC-1295: 3367.97 g/mol + Ipamorelin: 711.85 g/mol
- Class
- Dual-Pathway GH Research Blend
Research context.
The CJC-1295/Ipamorelin combination is one of the most widely studied GH-axis peptide pairings in preclinical research. Published data examines how concurrent GHRH receptor and ghrelin receptor stimulation may amplify GH output beyond either peptide alone.
Verification standard.
Certificate information is lot-specific. A finalized public record shows only the methods, fields, and results present for that named lot. A pending certificate state exposes no assay values and must not be interpreted as analytical verification. Review Nexus lab verification.
Certificate status.
Finalized independent certificate documentation is pending for this catalog record. Measurement details remain withheld until the certificate is available.
- Sequence
- Not listed
- Model preview
- Unavailable
Molecular model preview is unavailable for this catalog record.
The chemistry.
Combination of GHRH analog (CJC-1295) and GH secretagogue (Ipamorelin)
Technical specifications.
- Product Name: CJC-1295 No DAC + Ipamorelin Blend
- Classification: Dual-Pathway GH Research Blend
- Structural Description: Combination of GHRH analog (CJC-1295) and GH secretagogue (Ipamorelin)
- Molecular Weight: CJC-1295: 3367.97 g/mol + Ipamorelin: 711.85 g/mol
- Purity: ≥99% (verified by HPLC and Mass Spectrometry)
- Physical Form: Lyophilized (freeze-dried) powder
- Intended Use: In-vitro research use only — not for human consumption
Related research compounds
Comparable catalog records with published variants and certificate status.
- Growth Hormone SecretagoguesVerified batchCJC-1295 With DACPriceFrom $24.99Formats3 sizes
Compare size options, price, and certificate status before opening the product record.
CAS 446262-90-4View product - Growth Hormone SecretagoguesVerified batchCJC-1295 Without DACPriceFrom $23.99Formats3 sizes
Compare size options, price, and certificate status before opening the product record.
CAS 863288-34-0View product - Growth Hormone SecretagoguesVerified batchCJC-1295 without DAC 5mg + IPA 5mgPrice$62.99Formats1 size
Compare size options, price, and certificate status before opening the product record.
View product - Growth Hormone SecretagoguesVerified batchSermorelin AcetatePriceFrom $32.99Formats4 sizes
Compare size options, price, and certificate status before opening the product record.
CAS 86168-78-7View product - Growth Hormone SecretagoguesVerified batchTesamorelinPriceFrom $25.99Formats4 sizes
Compare size options, price, and certificate status before opening the product record.
CAS 218949-48-5View product
CJC-1295 without DAC 10mg + IPA 10mg research FAQ.
What is CJC-1295 without DAC 10mg + IPA 10mg used for in research?
CJC-1295 without DAC 10mg + IPA 10mg is supplied for controlled in-vitro research workflows in the Growth Hormone Secretagogues category. It is not labeled for human or veterinary use.
Does CJC-1295 without DAC 10mg + IPA 10mg have a finalized analytical record?
CJC-1295 without DAC 10mg + IPA 10mg is listed with certificate-pending status until a finalized lot-specific COA record is available.
Which CJC-1295 without DAC 10mg + IPA 10mg variants are published?
Published Nexus variants include 20mg.
Does CJC-1295 without DAC 10mg + IPA 10mg include a COA?
The current Nexus record marks CJC-1295 without DAC 10mg + IPA 10mg as certificate pending; finalized assay values are not shown until lot-specific documentation is available.